Stomach cancer is challenging to detect early due to vague symptoms, often diagnosed at advanced stages. Diagnosis involves ...
The Las Vegas Medical District is set to expand with a new testing facility that officials say will strengthen the region’s ...
Medical Device Network on MSN
Adaptyx raises $14m to advance molecular monitoring platform
US-based Adaptyx Biosciences has secured $14m to scale its bio-wearable that translates molecular data into actionable ...
Bent bone dysplasia (BBD) is a perinatal-lethal skeletal disorder caused by pathogenic FGFR2 mutations that disrupt bone ...
Multigene next-generation sequencing (NGS) performed directly on tumor tissue can accurately identify pathogenic variants in epithelial ovarian cancer (EOC), detecting both somatic and germline ...
Data at ESMO 2025 bolstered the case that blood tests could help doctors sort which patients need additional therapy, and who ...
Texas A&M researchers found that in an aggressive kidney cancer, RNA builds “droplet hubs” that activate tumor genes. By creating a molecular switch to dissolve these hubs, they stopped cancer growth ...
Study Acceptance Supports and Provides the Catalyst for Upcoming Commercial Rollout and Revenue-Generating Potential ...
Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...
Although COVID-19 testing decreased during the study period, influenza and respiratory syncytial virus testing increased among hospitalized youth.
What happens when you squeeze DNA? Can pressure reveal something about how our genetic material is packed, protected, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback